MERRIMACK PHARMACEUTICALS INC
DelistedCIK 1274792fmd_16RPR3QBM3PHPV6JX2EQQS5QP3Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Mar 31, 2024, 54 periods
Latest annual · FY2023
Millions- Operating income
- (2)
- Net income
- (1)
Latest quarter · Q1 FY2024
Millions- Operating income
- (1)
- Net income
- 201
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2018 to FY2023
- n/m
MERRIMACK PHARMACEUTICALS INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Operating income | -$2 million | -$1.7 million | 10-K 2024-03-07 · proof | |
| Net income | -$1.2 million | -$1.5 million | 10-K 2024-03-07 · proof | |
| Cash from operating activities | -$1.5 million | -$1.7 million | 10-K 2024-03-07 · proof | |
| Total assets | $19.2 million | $19.8 million | -3.3% | 10-K 2024-03-07 · proof |
| Total liabilities | $441,000 | $589,000 | -25.1% | 10-K 2024-03-07 · proof |
| Cash and cash equivalents | $6 million | $19.4 million | -69.2% | 10-K 2024-03-07 · proof |
- What was MERRIMACK PHARMACEUTICALS INC's operating income in fiscal 2023?
- MERRIMACK PHARMACEUTICALS INC reported operating income of -$2 million for fiscal 2023 (the year ended Dec 31, 2023), against -$1.7 million the year before. Source: the 10-K filed with the SEC on Mar 7, 2024. SEC
- What was MERRIMACK PHARMACEUTICALS INC's net income in fiscal 2023?
- MERRIMACK PHARMACEUTICALS INC reported net income of -$1.2 million for fiscal 2023 (the year ended Dec 31, 2023), against -$1.5 million the year before. Source: the 10-K filed with the SEC on Mar 7, 2024. SEC
- What was MERRIMACK PHARMACEUTICALS INC's cash from operating activities in fiscal 2023?
- MERRIMACK PHARMACEUTICALS INC reported cash from operating activities of -$1.5 million for fiscal 2023 (the year ended Dec 31, 2023), against -$1.7 million the year before. Source: the 10-K filed with the SEC on Mar 7, 2024. SEC
- What are MERRIMACK PHARMACEUTICALS INC's total assets?
- As of Dec 31, 2023, MERRIMACK PHARMACEUTICALS INC reported total assets of $19.2 million, against $19.8 million a year earlier (-3.3%). Source: the 10-K filed with the SEC on Mar 7, 2024. SEC
- What are MERRIMACK PHARMACEUTICALS INC's total liabilities?
- As of Dec 31, 2023, MERRIMACK PHARMACEUTICALS INC reported total liabilities of $441,000, against $589,000 a year earlier (-25.1%). Source: the 10-K filed with the SEC on Mar 7, 2024. SEC
- What are MERRIMACK PHARMACEUTICALS INC's cash and cash equivalents?
- As of Dec 31, 2023, MERRIMACK PHARMACEUTICALS INC reported cash and cash equivalents of $6 million, against $19.4 million a year earlier (-69.2%). Source: the 10-K filed with the SEC on Mar 7, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1274792&period_type=annual&limit=5"Information only, not investment advice.